ID20895A - Senyawa-senyawa piperazina dan piperidina baru - Google Patents

Senyawa-senyawa piperazina dan piperidina baru

Info

Publication number
ID20895A
ID20895A IDP981269A ID981269A ID20895A ID 20895 A ID20895 A ID 20895A ID P981269 A IDP981269 A ID P981269A ID 981269 A ID981269 A ID 981269A ID 20895 A ID20895 A ID 20895A
Authority
ID
Indonesia
Prior art keywords
piperazina
piperidine compounds
new piperidine
new
compounds
Prior art date
Application number
IDP981269A
Other languages
English (en)
Indonesian (id)
Inventor
Roelof W Feenstra
Jacobus A J Den Hartog
Cornelis G Kruse
Martinus T M Tulp
Stephen K Long
Original Assignee
Duphar Int Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duphar Int Res filed Critical Duphar Int Res
Publication of ID20895A publication Critical patent/ID20895A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
IDP981269A 1997-09-24 1998-09-21 Senyawa-senyawa piperazina dan piperidina baru ID20895A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97202950 1997-09-24

Publications (1)

Publication Number Publication Date
ID20895A true ID20895A (id) 1999-03-25

Family

ID=8228755

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP981269A ID20895A (id) 1997-09-24 1998-09-21 Senyawa-senyawa piperazina dan piperidina baru

Country Status (31)

Country Link
US (2) US6090812A (no)
EP (1) EP0908458B1 (no)
JP (1) JP4191826B2 (no)
KR (1) KR100632188B1 (no)
CN (1) CN1093857C (no)
AR (1) AR017127A1 (no)
AT (1) ATE316529T1 (no)
AU (1) AU733526B2 (no)
BR (1) BR9803497A (no)
CA (1) CA2247734C (no)
CY (1) CY1107494T1 (no)
CZ (1) CZ296741B6 (no)
DE (1) DE69833297T2 (no)
DK (1) DK0908458T3 (no)
DZ (1) DZ2613A1 (no)
ES (1) ES2255127T3 (no)
HK (1) HK1018272A1 (no)
HU (1) HU227422B1 (no)
ID (1) ID20895A (no)
IL (1) IL126295A (no)
NO (1) NO312835B1 (no)
NZ (1) NZ331984A (no)
PL (1) PL190622B1 (no)
PT (1) PT908458E (no)
RU (1) RU2197488C2 (no)
SI (1) SI0908458T1 (no)
SK (1) SK285205B6 (no)
TR (1) TR199801866A1 (no)
TW (1) TW530054B (no)
UA (1) UA66756C2 (no)
ZA (1) ZA988749B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6200994B1 (en) 1999-01-07 2001-03-13 American Home Products Corp 1,4-Disubstituted cyclohexane derivatives for the treatment of depression
CA2355361A1 (en) * 1999-01-07 2000-07-13 Richard Eric Mewshaw New 1,4-disubstituted cyclohexane derivatives for the treatment of depression
DE10005150A1 (de) * 2000-02-07 2001-08-09 Merck Patent Gmbh Verfahren zur Herstellung von 5-Arylnicotinaldehyden
DE10115922A1 (de) * 2001-03-30 2002-10-10 Bayer Ag Cyclisch substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung
EP2036547A3 (en) 2001-07-20 2009-12-23 Psychogenics Inc. Treatment for Attention-Deficit Hyperactivity Disorder
US7435738B2 (en) 2003-08-18 2008-10-14 Solvay Pharmaceuticals, Inc. Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)
US7405216B2 (en) 2004-08-18 2008-07-29 Solvay Pharmaceuticals, B.V. Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)
US7423040B2 (en) 2005-02-18 2008-09-09 Irene Eijgendaal Stable crystalline form of bifeprunox mesylate, dosage forms thereof and methods for using same
US7964604B2 (en) 2005-02-18 2011-06-21 Solvay Pharmaceuticals B.V. Bifeprunox mesylate maintenance dose compositions and methods for using the same
JP2009535374A (ja) 2006-05-02 2009-10-01 ソルベイ・フアーマシユーチカルズ・ベー・ブイ ピリジルメチルピペラジンおよび−ピペリジン誘導体のｎ−オキサイド
US20070275977A1 (en) * 2006-05-02 2007-11-29 Van Aar Marcel P N-oxides of pyridylmethyl -piperazine and -piperidine derivatives
US8106056B2 (en) 2006-06-16 2012-01-31 Solvay Pharmaceuticals B.V. Combination preparations comprising bifeprunox and a dopamine agonist
US7786126B2 (en) 2006-06-16 2010-08-31 Solvay Pharmaceuticals B.V. Combination preparations comprising SLV308 and a dopamine agonist
WO2011088838A1 (en) 2010-01-25 2011-07-28 H. Lundbeck A/S Novel 6,6a,7,8,9,10-hexahydro-4h-4,8,10a-triaza-acephenanthrylene derivatives as dopamine d2 ligands
US8877778B2 (en) * 2010-12-15 2014-11-04 Hoffmann-La Roche Inc. Benzofurane compounds
US8921397B2 (en) 2011-05-04 2014-12-30 Hoffmann-La Roche Inc. Benzofurane-piperidine compounds
CN109641871B (zh) 2016-07-20 2021-10-22 诺华股份有限公司 氨基吡啶衍生物及其作为选择性alk-2抑制剂的用途
KR101665971B1 (ko) 2016-08-10 2016-10-13 (주)글로벌 로보틱스 차량용 발포패드 부착장치
CR20220280A (es) 2019-11-22 2022-09-02 Incyte Corp Terapia de combinación que comprende un inhibidor de alk2 y un inhibidor de jak2
CA3187767A1 (en) 2020-06-16 2021-12-23 Incyte Corporation Alk2 inhibitors for the treatment of anemia

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE81975T1 (de) 1984-12-21 1992-11-15 Duphar Int Res Arzneimittel mit psychotroper wirkung.
DE3571436D1 (en) * 1984-12-21 1989-08-17 Duphar Int Res New pharmaceutical compositions having anti-psychotic properties
IL81669A (en) * 1986-02-27 1990-11-29 Duphar Int Res Aryl-substituted(n-piperidinyl)methyl-and(n-piperazinyl)-methylazoles,their preparation and pharmaceutical compositions containing them
EP0508347A1 (en) 1991-04-10 1992-10-14 Hoechst Aktiengesellschaft 5,7-Dihydroxy-2-methyl-8-[4-(3-hydroxy-1-(1-propyl)) piperidinyl]-4H-1-benzopyran-4-one, its preparation and its use
IE914218A1 (en) * 1991-09-11 1993-03-24 Mcneilab Inc Novel 4-arylpiperazines and 4-arylpiperidines
JPH05262765A (ja) 1992-03-18 1993-10-12 Sumitomo Chem Co Ltd ベンゾフラン誘導体およびそれを有効成分とする除草剤
FR2692264B1 (fr) * 1992-06-12 1994-08-05 Adir Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant.
US5332732A (en) * 1992-09-11 1994-07-26 Mcneilab, Inc. Thiophene and pyridine antipsychotic agents
US5436246A (en) * 1992-09-17 1995-07-25 Merrell Dow Pharmaceuticals Inc. Serotonin receptor agents
RU2118322C1 (ru) * 1993-07-05 1998-08-27 Дюфар Интернэшнл Рисерч Б.В. 2,3-дигидро-1,4-бензодиокси-5-ил-пиперазиновые производные или их соли
GB9314758D0 (en) * 1993-07-16 1993-08-25 Wyeth John & Brother Ltd Heterocyclic derivatives
EP0650964A1 (en) 1993-11-02 1995-05-03 Duphar International Research B.V 1 2H-1-benzopyran-2-one-8-yl -piperazine derivatives
DE4425146A1 (de) * 1994-07-15 1996-01-18 Basf Ag Verwendung heterocyclischer Verbindungen
US5607936A (en) * 1994-09-30 1997-03-04 Merck & Co., Inc. Substituted aryl piperazines as neurokinin antagonists
US6114334A (en) * 1995-07-13 2000-09-05 Knoll Aktiengesellschaft Piperazine derivatives as therapeutic agents
EP0889889B1 (en) * 1996-03-29 2006-09-20 Duphar International Research B.V Piperazine and piperidine compounds
DE19637237A1 (de) * 1996-09-13 1998-03-19 Merck Patent Gmbh Piperazin-Derivate

Also Published As

Publication number Publication date
TW530054B (en) 2003-05-01
IL126295A (en) 2003-02-12
DE69833297D1 (de) 2006-04-13
HUP9802129A1 (hu) 2000-03-28
US6090812A (en) 2000-07-18
NO984380L (no) 1999-03-25
SK285205B6 (sk) 2006-08-03
IL126295A0 (en) 1999-05-09
BR9803497A (pt) 2000-05-02
CA2247734A1 (en) 1999-03-24
ZA988749B (en) 1999-03-26
AR017127A1 (es) 2001-08-22
HU9802129D0 (en) 1998-11-30
KR19990029982A (ko) 1999-04-26
PL190622B1 (pl) 2005-12-30
CN1093857C (zh) 2002-11-06
PT908458E (pt) 2006-05-31
JP4191826B2 (ja) 2008-12-03
CA2247734C (en) 2007-08-07
KR100632188B1 (ko) 2007-04-25
CY1107494T1 (el) 2013-03-13
NO984380D0 (no) 1998-09-21
HK1018272A1 (en) 1999-12-17
USRE41425E1 (en) 2010-07-06
SI0908458T1 (sl) 2006-06-30
ES2255127T3 (es) 2006-06-16
EP0908458B1 (en) 2006-01-25
EP0908458A1 (en) 1999-04-14
AU8607998A (en) 1999-04-15
UA66756C2 (uk) 2004-06-15
NO312835B1 (no) 2002-07-08
ATE316529T1 (de) 2006-02-15
AU733526B2 (en) 2001-05-17
SK129498A3 (en) 1999-04-13
DZ2613A1 (fr) 2003-03-01
RU2197488C2 (ru) 2003-01-27
DE69833297T2 (de) 2006-07-20
CN1220265A (zh) 1999-06-23
CZ303098A3 (cs) 1999-04-14
NZ331984A (en) 2000-02-28
PL328754A1 (en) 1999-03-29
JPH11302279A (ja) 1999-11-02
TR199801866A1 (xx) 1999-04-21
HU227422B1 (en) 2011-05-30
CZ296741B6 (cs) 2006-06-14
DK0908458T3 (da) 2006-06-06

Similar Documents

Publication Publication Date Title
ID29591A (id) Senyawa-senyawa kuinolina dan kuinoksalina
ID19422A (id) Piridina dan bifenil tersubstitusi
ID20895A (id) Senyawa-senyawa piperazina dan piperidina baru
ID21781A (id) Benzamidoaldehida baru dan penggunaannya
ID29306A (id) Bentuk baru s-omeprazola
ID17686A (id) Fotoinisiator alpha-aminoasetofenon baru
ID24839A (id) Senyawa-senyawa triazol dan penggunaannya
ID23575A (id) Pirazolopirimidina-pirazolopirimidina dan pirazolotriazina-pirazolotriazina
ID23684A (id) Komposisi-polimer-organoclay dan pembuatannya
ID24476A (id) Arilsulfonamida dan analognya
ID21881A (id) Turunan-turunan baru pirazol tersubstitusi
ID24176A (id) Bahan pembantu sementasi
ID15840A (id) Turunan-turunan 19-nor-pregnena baru
ID28114A (id) Sitokin mamalia; interleukin-b30 dan pereaksi-pereaksi terkait
ID16079A (id) Poliisosianat terblok baru dan penggunaanya
DE69826891D1 (de) Piperidinderivate
ID16889A (id) Senyawa turunan alkilaminobenzotiazol dan benzoksazol
NO20002659D0 (no) Trombinreseptorantagonister
ID18456A (id) Produksi-bersama 6-aminokapronitril dan heksametilenadiamina
ID21525A (id) Komposisi bedak baru
ID18431A (id) Senyawa-senyawa baru
ID16660A (id) Senyawa-senyawa b-laktam monosiklik baru
ID24716A (id) Formulasi baru
ID18459A (id) Produksi-bersama 6-aminokapronitril dan heksametilenadiamina
ID16587A (id) Koproduksi 6-aminokapronitril dan heksametilendiamin